Portfolio Lab

Becton Dickinson & Co

  • Stock
  • Ticker BDX
  • ISIN US0758871091
  • NYSE

Health care · Medical technology · USA

$212.78 +0.05%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Becton Dickinson & Co since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

BDXGlobal equities (VT)

$10,000 grew to $18,870. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −40.1% in 05/2025, measured from the peak in 07/2023. It took 39 months to get back to the old peak.

1-year return
+46.3%
5-year return p.a.
+4.1%
10-year return p.a.
+6.6%
Volatility p.a.
21.5%
Largest decline
−40.1%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end09/202412/202403/202506/202509/202512/202503/202606/2026
Income statement
Revenue5,4375,1684,4804,7268,3015,2524,7144,983
Gross profit2,4872,2351,8612,2354,0322,4112,1542,315
Operating income6224533837391,17455293663
EBITDA1,2081,0609501,3141,9301,1666561,227
Net income400303308574493382-311377
Earnings per share1.371.041.072.001.721.34-1.111.37
Balance sheet
Total assets57,28654,66554,46754,90255,32554,84150,83250,731
Liabilities31,39629,46029,22629,43029,93529,55926,69926,315
Equity25,89025,20525,24125,47225,39025,28224,13324,416
Cash1,717711667735567740813708
Long-term debt17,94017,44017,66617,53117,62016,91614,70613,511
Cash flow
Operating cash flow1,178693-2041,0891,852657671776
Capital expenditure-296-105-114-164-377-108-125-143
Free cash flow882588-3189251,475549546633

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2017 at +31.2%, weakest 2025 at −12.6%. 5 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
6 Aug 2026$1.37
7 May 2026−$1.11
9 Feb 2026$1.34
25 Nov 2025$1.72
7 Aug 2025$2.00
1 May 2025$1.07
6 Feb 2025$1.04
27 Nov 2024$1.37
1 Aug 2024$1.68
2 May 2024$1.85
1 Feb 2024$0.96
21 Nov 2023$0.34

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€53bn
Market cap in trading currency
$58.0bn
Enterprise value
$74.1bn
P/E
64.1
P/S
2.49
P/B
2.37
EV/Sales
3.19
EV/EBITDA
14.9
Earnings yield
1.6%
FCF yield
5.5%

Results (last four quarters)

Revenue
$23.3bn
Gross profit
$10.9bn
EBITDA
$4.98bn
Net income
$941m
Earnings per share
$3.32
Revenue per share
$85.36
Revenue growth
+5.4%
Earnings growth
−34.3%

Profitability

Gross margin
46.9%
Operating margin
10.7%
Net margin
4.0%
Return on equity
3.8%
Return on assets
1.9%

Balance sheet and cash flow

Cash
$708m
Cash per share
$2.60
Financial debt
$16.8bn
Debt/equity %
69
Current ratio
0.87
Book value per share
$89.64
Operating cash flow
$3.96bn
Free cash flow
$3.20bn

Dividend

Dividend yield
1.87%
Dividend (12 months)
$3.98
Yield (12 months)
1.87%
Payout ratio
120%
Ex-dividend date
9 Sep 2026

Shares and trading

Shares outstanding
272m
Volume
1.94m
Avg. volume 3 months
1.81m
Relative volume
1.1

Price and technicals

Price
$212.78
1 day
0.0%
52-week high
$218.03
52-week low
$140.71
Distance to 52-week high
−2.4%
Distance to 52-week low
+51.2%
Distance to 50-day line
+9.4%
Distance to 200-day line
+25.3%
RSI (14)
63
Volatility 1M
24.5%

Performance

1 week
−2.4%
1 month
+6.2%
3 months
+11.6%
6 months
+44.1%
YTD
+39.5%
1 year
+41.5%

Dates

Fiscal year end
30 Sep 2025
Most recent quarter
30 Jun 2026

Frequently asked questions

How has BDX performed since 11/2016?

$10,000 grew to $18,870 by 20 Nov 2026, which is +6.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is BDX?

Volatility was 21.5% per year, measured on monthly returns. The largest decline from a peak was −40.1%, with the low in 05/2025.

How does BDX compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, BDX returned +6.6% at 21.5%. The correlation of monthly returns was 0.32; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Becton Dickinson & Co (BDX): Return and risk | Portfolio Lab